Alexandrina Pinta

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The objective of the present study was to evaluate the virological efficacy of a 3-month short-course intensification with enfuvirtide (ENF) associated with an optimized background regimen (OBR) in(More)
Ribavirin remains today a pivotal drug in the treatment of hepatitis C; in standard double therapy, as well as in triple combination with direct antiviral agents, ribavirin reduces relapse and can(More)
  • 1